AwardedPOLGoodsPLN 2,184,756
Zakup leków antyretrowirusowych. Części 1÷3
- Published
- Published 25 March 2026
- Deadline
- Closed 23 April 2026
Overview
The National AIDS Centre procured antiretroviral medications across three parts: Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide, Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil, and Raltegravir tablets, with delivery to a depot warehouse. The contract was awarded on 7 May 2026 to Gilead Sciences Poland Sp. z o. o. and Urtica Sp. z o. o. for a total value of 2,574,641.56 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Estimated value
- PLN 2,184,756
- Procedure
- Open
- Published
- 25 March 2026
- Deadline
- Closed
Antivirals for systemic use
Award outcome
- Awarded value
- PLN 2,574,642
- Award date
- 7 May 2026
- Contract period
- — → 12 May 2026
- Gilead Sciences Poland Sp. z o. o.
- Urtica Sp. z o. o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
22 June 2026
Contract Notice
25 March 2026
Contracting authority
Krajowe Centrum ds. AIDS
Procuring entityWarszawa, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.